Oxatomide in Seasonal Rhinoconjunctivitis
- 1 June 1980
- Vol. 35 (4) , 319-322
- https://doi.org/10.1111/j.1398-9995.1980.tb01773.x
Abstract
The new antiallergic drug oxatomide [an H-1 receptor antagonist] was evaluated in 40 schoolchildren suffering from severe allergic seasonal rhinoconjunctivitis [due to deciduous tree allergy]. Antihistamine drugs had earlier given insufficient symptomatic relief. Double-blind technique was used. There was no significant different in the effect of oxatomide and the effect of the antihistamine cinnarizine in combination with phenylpropanolamine and placebo. The hypothesis that oxatomide is superior to antihistamine drugs in the treatment of severe seasonal rhinoconjunctivitis is not supported.Keywords
This publication has 2 references indexed in Scilit:
- Morphological Evaluation of Oxatomide – a New Anti-Allergic Drug in Guinea Pig AnaphylaxisInternational Archives of Allergy and Immunology, 1978
- Oxatomide, a new orally active drug which inhibits both the release and the effects of allergic mediatorsCellular and Molecular Life Sciences, 1977